Logo image of VXX

IPATH SERIES B S&P 500 VIX (VXX) Stock Overview

USA - NYSEARCA:VXX - US06748M1962 - ETF

32 USD
-1.08 (-3.26%)
Last: 10/27/2025, 8:04:00 PM
32 USD
0 (0%)
After Hours: 10/27/2025, 8:04:00 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to VXX. VXX was compared to 390 industry peers in the Banks industry. VXX may be in some trouble as it scores bad on both profitability and health. VXX is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

VXX had positive earnings in the past year.
VXX had a negative operating cash flow in the past year.
Each year in the past 5 years VXX has been profitable.
Of the past 5 years VXX 4 years had a positive operating cash flow.
VXX Yearly Net Income VS EBIT VS OCF VS FCFVXX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B 40B 60B

1.2 Ratios

VXX has a Return On Assets of 0.59%. This is in the lower half of the industry: VXX underperforms 71.28% of its industry peers.
With an excellent Return On Equity value of 12.49%, VXX belongs to the best of the industry, outperforming 84.36% of the companies in the same industry.
Industry RankSector Rank
ROA 0.59%
ROE 12.49%
ROIC N/A
ROA(3y)0.32%
ROA(5y)0.31%
ROE(3y)6.92%
ROE(5y)6.41%
ROIC(3y)N/A
ROIC(5y)N/A
VXX Yearly ROA, ROE, ROICVXX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 -2 4 6 8

1.3 Margins

VXX has a worse Profit Margin (20.33%) than 63.33% of its industry peers.
VXX's Profit Margin has improved in the last couple of years.
The Operating Margin and Gross Margin are not available for VXX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 20.33%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-11.91%
PM growth 5Y11.07%
GM growth 3YN/A
GM growth 5YN/A
VXX Yearly Profit, Operating, Gross MarginsVXX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

1

2. Health

2.1 Basic Checks

VXX does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for VXX has been reduced compared to 1 year ago.
Compared to 5 years ago, VXX has less shares outstanding
Compared to 1 year ago, VXX has about the same debt to assets ratio.
VXX Yearly Shares OutstandingVXX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B
VXX Yearly Total Debt VS Total AssetsVXX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500B 1T 1.5T

2.2 Solvency

A Debt/Equity ratio of 3.86 is on the high side and indicates that VXX has dependencies on debt financing.
VXX's Debt to Equity ratio of 3.86 is on the low side compared to the rest of the industry. VXX is outperformed by 94.62% of its industry peers.
Industry RankSector Rank
Debt/Equity 3.86
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC6.03%
VXX Yearly LT Debt VS Equity VS FCFVXX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B 40B 60B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
VXX Yearly Current Assets VS Current LiabilitesVXX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 124.39% over the past year.
The Earnings Per Share has been growing by 11.00% on average over the past years. This is quite good.
The Revenue has been growing slightly by 5.48% in the past year.
The Revenue has been growing slightly by 5.03% on average over the past years.
EPS 1Y (TTM)124.39%
EPS 3Y0.56%
EPS 5Y11%
EPS Q2Q%291.9%
Revenue 1Y (TTM)5.48%
Revenue growth 3Y7.82%
Revenue growth 5Y5.03%
Sales Q2Q%10.84%

3.2 Future

VXX is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.69% yearly.
VXX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.05% yearly.
EPS Next Y8.76%
EPS Next 2Y15.3%
EPS Next 3Y14.66%
EPS Next 5Y8.69%
Revenue Next Year8.62%
Revenue Next 2Y6.67%
Revenue Next 3Y5.63%
Revenue Next 5Y4.05%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
VXX Yearly Revenue VS EstimatesVXX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 10B 20B 30B
VXX Yearly EPS VS EstimatesVXX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 7.79, the valuation of VXX can be described as very cheap.
91.79% of the companies in the same industry are more expensive than VXX, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of VXX to the average of the S&P500 Index (27.08), we can say VXX is valued rather cheaply.
With a Price/Forward Earnings ratio of 11.54, the valuation of VXX can be described as very reasonable.
VXX's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. VXX is more expensive than 64.87% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.09. VXX is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 7.79
Fwd PE 11.54
VXX Price Earnings VS Forward Price EarningsVXX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
VXX Per share dataVXX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

VXX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
VXX's earnings are expected to grow with 14.66% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.89
PEG (5Y)0.71
EPS Next 2Y15.3%
EPS Next 3Y14.66%

3

5. Dividend

5.1 Amount

VXX has a Yearly Dividend Yield of 2.19%. Purely for dividend investing, there may be better candidates out there.
The stock price of VXX dropped by -30.30% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
Compared to an average industry Dividend Yield of 3.50, VXX is paying slightly less dividend.
Compared to an average S&P500 Dividend Yield of 2.30, VXX has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.19%

5.2 History

On average, the dividend of VXX grows each year by 6.61%, which is quite nice.
VXX does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)6.61%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

VXX's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DPN/A
EPS Next 2Y15.3%
EPS Next 3Y14.66%
VXX Yearly Income VS Free CF VS DividendVXX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B 40B

IPATH SERIES B S&P 500 VIX

NYSEARCA:VXX (10/27/2025, 8:04:00 PM)

After market: 32 0 (0%)

32

-1.08 (-3.26%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)10-22 2025-10-22/bmo
Earnings (Next)02-11 2026-02-11/amc
Inst Owners55.08%
Inst Owner Change6.41%
Ins Owners0.13%
Ins Owner ChangeN/A
Market Cap111.61B
Revenue(TTM)47.27B
Net Income(TTM)9.48B
Analysts79.09
Price Target36.45 (13.91%)
Short Float %0.2%
Short Ratio0.82
Dividend
Industry RankSector Rank
Dividend Yield 2.19%
Yearly Dividend0.82
Dividend Growth(5Y)6.61%
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)15.23%
Min EPS beat(2)13.75%
Max EPS beat(2)16.7%
EPS beat(4)4
Avg EPS beat(4)29.84%
Min EPS beat(4)13.75%
Max EPS beat(4)64.16%
EPS beat(8)8
Avg EPS beat(8)28.97%
EPS beat(12)12
Avg EPS beat(12)22.72%
EPS beat(16)16
Avg EPS beat(16)27.45%
Revenue beat(2)2
Avg Revenue beat(2)2.74%
Min Revenue beat(2)1.38%
Max Revenue beat(2)4.11%
Revenue beat(4)4
Avg Revenue beat(4)2.75%
Min Revenue beat(4)1.38%
Max Revenue beat(4)4.11%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-3.13%
PT rev (3m)-28.5%
EPS NQ rev (1m)-7.89%
EPS NQ rev (3m)-11.11%
EPS NY rev (1m)-4.3%
EPS NY rev (3m)-5.57%
Revenue NQ rev (1m)0.94%
Revenue NQ rev (3m)-0.58%
Revenue NY rev (1m)0.09%
Revenue NY rev (3m)1.13%
Valuation
Industry RankSector Rank
PE 7.79
Fwd PE 11.54
P/S 1.8
P/FCF N/A
P/OCF N/A
P/B 1.1
P/tB 1.24
EV/EBITDA N/A
EPS(TTM)4.11
EY12.84%
EPS(NY)2.77
Fwd EY8.67%
FCF(TTM)-3.87
FCFYN/A
OCF(TTM)-3.87
OCFYN/A
SpS17.79
BVpS28.96
TBVpS25.84
PEG (NY)0.89
PEG (5Y)0.71
Graham Number51.75
Profitability
Industry RankSector Rank
ROA 0.59%
ROE 12.49%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 20.33%
GM N/A
FCFM N/A
ROA(3y)0.32%
ROA(5y)0.31%
ROE(3y)6.92%
ROE(5y)6.41%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-11.91%
PM growth 5Y11.07%
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 3.86
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score5
WACC6.03%
ROIC/WACCN/A
Cap/Depr(3y)89.52%
Cap/Depr(5y)85.55%
Cap/Sales(3y)5.72%
Cap/Sales(5y)5.93%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)124.39%
EPS 3Y0.56%
EPS 5Y11%
EPS Q2Q%291.9%
EPS Next Y8.76%
EPS Next 2Y15.3%
EPS Next 3Y14.66%
EPS Next 5Y8.69%
Revenue 1Y (TTM)5.48%
Revenue growth 3Y7.82%
Revenue growth 5Y5.03%
Sales Q2Q%10.84%
Revenue Next Year8.62%
Revenue Next 2Y6.67%
Revenue Next 3Y5.63%
Revenue Next 5Y4.05%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-25.18%
FCF growth 3Y-51.04%
FCF growth 5YN/A
OCF growth 1Y-25.18%
OCF growth 3Y-47.42%
OCF growth 5YN/A

IPATH SERIES B S&P 500 VIX / VXX FAQ

What does VXX do?

Barclays PLC is a bank holding company, which engages in the provision of retail banking, credit cards, corporate and investment banking, and wealth management services. The Barclays UK division represents businesses that sit within the United Kingdom ring-fenced bank, Barclays Bank UK PLC and its subsidiaries, and comprises Personal Banking, UK Business Banking and Barclaycard Consumer UK. The Barclays UK Corporate Bank division offers lending, trade and working capital, liquidity, payments, and FX solutions for corporate clients. Barclays Private Bank and Wealth Management division comprises the Private Bank, Wealth Management, and Investments businesses. Barclays Investment Bank division incorporates the Global Markets, Investment Banking, and International Corporate Banking businesses. Barclays US Consumer Bank division represents the United States credit card business, focused on the partnership market, as well as an online deposit franchise.


Can you provide the latest stock price for IPATH SERIES B S&P 500 VIX?

The current stock price of VXX is 32 USD. The price decreased by -3.26% in the last trading session.


What is the ChartMill technical and fundamental rating of VXX stock?

VXX has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.


Is IPATH SERIES B S&P 500 VIX (VXX) stock a good buy?

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on VXX.